Andreas Kulawik
Juelich, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting.
Journal: NPJ Parkinson's disease
Published: November 27, 2021
Advancements of the sFIDA method for oligomer-based diagnostics of neurodegenerative diseases.
Journal: FEBS letters
Published: December 03, 2017
IL-1β-induced and p38MAPK-dependent activation of the mitogen-activated protein kinase-activated protein kinase 2 (MK2) in hepatocytes: Signal transduction with robust and concentration-independent signal amplification.
Journal: The Journal of biological chemistry
Published: January 09, 2017
Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: November 14, 2016
Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 30, 2016
sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body fluids.
Journal: Clinical biochemistry
Published: June 13, 2016
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay.
Journal: Biological chemistry
Published: March 18, 2016
Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay.
Journal: Frontiers in neuroscience
Published: November 10, 2015
Single fibril growth kinetics of α-synuclein.
Journal: Journal of molecular biology
Published: September 19, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026